RIXJUVANT Trademark

Trademark Overview


On Monday, September 19, 2005, a trademark application was filed for RIXJUVANT with the United States Patent and Trademark Office. The USPTO has given the RIXJUVANT trademark a serial number of 78715345. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 21, 2014. This trademark is owned by GlaxoSmithKline Biologicals, S.A.. The RIXJUVANT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical and medicinal preparations and substances for the treatment and/or prevention of infectious and non-infectious diseases
rixjuvant

General Information


Serial Number78715345
Word MarkRIXJUVANT
Filing DateMonday, September 19, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 21, 2014
Registration Number3264360
Registration DateTuesday, July 17, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2007

Trademark Statements


Goods and Servicespharmaceutical and medicinal preparations and substances for the treatment and/or prevention of infectious and non-infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 21, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals, S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, February 21, 2014CANCELLED SEC. 8 (6-YR)
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 17, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, May 1, 2007PUBLISHED FOR OPPOSITION
Wednesday, April 11, 2007NOTICE OF PUBLICATION
Thursday, March 8, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 7, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2007ASSIGNED TO LIE
Tuesday, January 30, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 2, 2006INQUIRY TO SUSPENSION E-MAILED
Wednesday, August 2, 2006SUSPENSION INQUIRY WRITTEN
Tuesday, June 27, 2006LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, December 6, 2005LETTER OF SUSPENSION E-MAILED
Tuesday, December 6, 2005SUSPENSION LETTER WRITTEN
Tuesday, November 29, 2005ASSIGNED TO EXAMINER
Monday, September 26, 2005NEW APPLICATION ENTERED IN TRAM